Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.55 Million USD | 28.75% |
| 2022 | 4.33 Million USD | -36.41% |
| 2021 | 6.8 Million USD | -8.15% |
| 2020 | 7.41 Million USD | 138.97% |
| 2019 | 3.1 Million USD | 3233.33% |
| 2018 | -99 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | 2.72 Million USD | 22.02% |
| 2023 Q1 | 2.23 Million USD | 215.54% |
| 2023 Q3 | 1.94 Million USD | -28.76% |
| 2023 Q4 | -577 Thousand USD | -129.71% |
| 2023 FY | 5.57 Million USD | 28.75% |
| 2022 Q4 | 708 Thousand USD | -45.5% |
| 2022 Q3 | 1.29 Million USD | -47.64% |
| 2022 FY | 4.33 Million USD | -36.41% |
| 2022 Q2 | 2.48 Million USD | 21.74% |
| 2022 Q1 | 2.03 Million USD | 800.34% |
| 2021 FY | 6.8 Million USD | -8.15% |
| 2021 Q4 | -291 Thousand USD | -111.48% |
| 2021 Q3 | 2.53 Million USD | 8.61% |
| 2021 Q2 | 2.33 Million USD | 4.62% |
| 2021 Q1 | 2.23 Million USD | -1.8% |
| 2020 Q4 | 2.27 Million USD | 9.6% |
| 2020 Q3 | 2.07 Million USD | 128.56% |
| 2020 Q2 | 907 Thousand USD | -58.03% |
| 2020 Q1 | 2.16 Million USD | 44.94% |
| 2020 FY | 7.41 Million USD | 138.97% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 3.1 Million USD | 3233.33% |
| 2019 Q3 | 957 Thousand USD | 46.33% |
| 2019 Q4 | 1.49 Million USD | 55.8% |
| 2019 Q2 | 654 Thousand USD | 0.0% |
| 2018 FY | -99 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Journey Medical Corporation | 52.52 Million USD | 87.517% |
| Safety Shot Inc | -74.45 Thousand USD | 8905.082% |
| Bright Green Corporation | -237.01 Thousand USD | 2866.058% |
| Alvotech | -69.42 Million USD | 109.444% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 77.965% |
| Cosmos Health Inc. | 4.34 Million USD | -50.728% |
| Dynavax Technologies Corporation | 182.11 Million USD | 96.4% |
| Embecta Corp. | 749.9 Million USD | 99.126% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 91.027% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 98.478% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 98.663% |
| PainReform Ltd. | -15 Thousand USD | 43806.667% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 21.383% |
| SCYNEXIS, Inc. | 124.51 Million USD | 94.735% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -1083.455% |
| Alpha Teknova, Inc. | 10.29 Million USD | 36.325% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 97.853% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 97.99% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 21.383% |
| Procaps Group, S.A. | 239.56 Million USD | 97.263% |
| Theratechnologies Inc. | 62.12 Million USD | 89.448% |
| Harrow Health, Inc. | 90.55 Million USD | 92.76% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -38.166% |
| Biofrontera Inc. | 16.62 Million USD | 60.57% |
| DURECT Corporation | 6.83 Million USD | 4.026% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 98.748% |
| Cronos Group Inc. | 6.99 Million USD | 6.221% |
| OptiNose, Inc. | 62.35 Million USD | 89.486% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 98.514% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 2263.696% |
| RedHill Biopharma Ltd. | 3.05 Million USD | -114.657% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 97.884% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | -21.531% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 80.422% |
| Radius Health, Inc. | 307.71 Million USD | 97.869% |
| Universe Pharmaceuticals INC | 10.07 Million USD | 34.947% |
| ProPhase Labs, Inc. | 16.23 Million USD | 59.628% |
| Phibro Animal Health Corporation | 312.48 Million USD | 97.902% |
| Procaps Group S.A. | 239.56 Million USD | 97.263% |
| TherapeuticsMD, Inc. | 1.3 Million USD | -403.533% |
| Viatris Inc. | 6.43 Billion USD | 99.898% |
| Rockwell Medical, Inc. | 8.7 Million USD | 24.678% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 87.99% |
| SIGA Technologies, Inc. | 122.09 Million USD | 94.63% |
| Tilray Brands, Inc. | 223.35 Million USD | 97.065% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 84.335% |
| Shineco, Inc. | 882.16 Thousand USD | -643.169% |
| PetIQ, Inc. | 252.74 Million USD | 97.406% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 979.306% |
| Incannex Healthcare Limited | 12 Thousand USD | -54533.333% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 99.645% |
| Alimera Sciences, Inc. | 61.17 Million USD | 89.282% |
| Silver Spike Investment Corp. | 8.1 Million USD | 19.088% |
| Assertio Holdings, Inc. | 125.04 Million USD | 94.757% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 96356.056% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | -56.424% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 372.013% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 75.823% |
| Hempacco Co., Inc. | -1.21 Million USD | 639.219% |
| Talphera, Inc. | -4.89 Million USD | 233.933% |
| Alvotech | -69.42 Million USD | 109.444% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 97.043% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 99.076% |
| Currenc Group, Inc. | 17.35 Million USD | 62.227% |
| Kamada Ltd. | 52.59 Million USD | 87.534% |
| Indivior PLC | 907 Million USD | 99.277% |
| Evoke Pharma, Inc. | 4.97 Million USD | -31.68% |
| Flora Growth Corp. | 17.73 Million USD | 63.04% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 372.013% |
| Evolus, Inc. | 140.52 Million USD | 95.335% |
| HUTCHMED (China) Limited | 453.55 Million USD | 98.555% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 98.094% |
| Akanda Corp. | 111.44 Thousand USD | -5782.511% |